Table 1 Patient characteristics
Hanoi province | Thanh Hoa province | Total | |
|---|---|---|---|
Total | 494 | 168 | 662 |
Gender | n = 494 | n = 168 | n = 662 |
Male | 365 (73.9%) | 141 (83.9%) | 506 (76.4%) |
Female | 129 (26.1%) | 27 (16.1%) | 156 (23.6%) |
Age (years) | n = 494 | n = 167 | n = 661 |
Mean (IQR) | 43.0 (32.0–55.0) | 44.0 (33.0–56.0) | 43.0 (32.0–55.0) |
By group (years) | |||
≤ 19 | 12 (2.4%) | 1 (0.6%) | 13 (2.0%) |
20–39 | 204 (41.3%) | 64 (38.3%) | 268 (40.5%) |
40–59 | 207 (41.9%) | 71 (42.5%) | 278 (42.1%) |
60–79 | 69 (14.0%) | 29 (17.4%) | 98 (14.8%) |
≥ 80 | 2 (0.4%) | 2 (1.2%) | 4 (0.6%) |
Not reported | 0 | 1 | 1 |
Previous TB treatment | n = 478 | n = 165 | n = 643 |
Yes | 394 (82.4%) | 138 (83.6%) | 532 (82.7%) |
No | 84 (17.6%) | 27 (16.4%) | 111 (17.3%) |
Not reported | 16 | 3 | 19 |
Financially supported through social health insurance | n = 311 | n = 147 | n = 458 |
Yes | 224 (72.0%) | 109 (74.1%) | 333 (72.7%) |
No | 87 (28.0%) | 38 (25.9%) | 125 (27.3%) |
Not reported | 183 | 21 | 204 |
HIV status | n = 453 | n = 74 | n = 527 |
Positive | 32 (7.1%) | 5 (6.8%) | 37 (7.0%) |
Negative | 421 (92.9%) | 69 (93.2%) | 490 (93.0%) |
Not reported | 41 | 94 | 135 |
Other comorbidities | n = 312 | n = 146 | n = 458 |
Diabetes | 44 (14.1%) | 8 (5.5%) | 52 (11.4%) |
Heart disease | 12 (3.8%) | 6 (4.1%) | 18 (3.9%) |
Liver disease | 13 (4.2%) | 7 (4.8%) | 20 (4.4%) |
Kidney disease | 2 (0.6%) | 0 (0%) | 2 (0.4%) |
Malnutrition | 7 (2.2%) | 7 (4.8%) | 14 (3.1%) |
Psychiatric disorder | 13 (4.2%) | 0 (0%) | 13 (2.8%) |
Respiratory disordera | 32 (10.3%) | 22 (15.1%) | 54 (11.8%) |
Substance abuse | 8 (2.6%) | 10 (6.8%) | 18 (3.9%) |
Otherb | 10 (3.2%) | 3 (2.1%) | 13 (2.8%) |
Not reported | 182 | 22 | 204 |
Infection site | n = 481 | n = 164 | n = 645 |
Pulmonary | 458 (95.2%) | 164 (100.0%) | 622 (96.4%) |
Extra-pulmonary | 12 (2.5%) | 0 (0%) | 12 (1.9%) |
Both | 11 (2.3%) | 0 (0%) | 11 (1.7%) |
Not reported | 13 | 4 | 17 |
Initial sputum smear grade | n = 474 | n = 146 | n = 620 |
Negative | 162 (34.2%) | 66 (45.2%) | 228 (36.8%) |
Scanty | 8 (1.7%) | 6 (4.1%) | 14 (2.3%) |
1 + | 185 (39.0%) | 23 (15.8%) | 208 (33.5%) |
2 + | 54 (11.4%) | 26 (17.8%) | 80 (12.9%) |
3 + | 65 (13.7%) | 25 (17.1%) | 90 (14.5%) |
Not reported | 20 | 22 | 42 |
Antibiotic resistance at enrolment | n = 309 | n = 132 | n = 441 |
RR-/MDR-TB only | 257 (83.2%) | 131 (98.5%) | 388 (88.0%) |
Pre-XDR-TB | 35 (11.3%) | 1 (1.5%) | 36 (8.2%) |
XDR-TB | 17 (5.5%) | 0 (0%) | 17 (3.8%) |
Not reported | 185 | 36 | 221 |